Editas Medicine Inc. (EDIT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Editas Medicine Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Editas Medicine Inc. (EDIT) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $399M. It trades at $2.95, up 13.46% today. Its overall quality score is 49 out of 100, ranked against the whole US market. 8 analysts' average target of $5.67 implies +92.2% from today's price. Kronos AI's 30-day forecast is +5.9% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $5.67 |
| Low – high | $4.00 – $8.00 |
| Analysts | 8 |
| Upside to average | +92.2% |
Kronos AI 30-day forecast
| Expected close | $2.75 (+5.9%) |
| Likely range | +0.7% … +11.1% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 10 |
| Solvency | 54 |
| Growth | 82 |
| Overall | 49 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator